APLN and breast cancer: Although untreated NeuT;Apln+/+ mammary tumors are not highly metastatic, sunitinib treatment significantly increased the number of lung metastases (Fig 6A), as previously observed (Ebos et al, 2009; Pàez‐Ribes et al, 2009).